1. Calabresi P, Parks RE Jr. Alkylating agents, antimetabolites, hormones and other antiproliferative agents. In: Goodman LS, Gilman A, eds. The Pharmacological Bases of Therapeutics. New York: MacMillan. 1975: 1254–1268.
2. Karnofsky DA. Summary of results obtained with nitrogen mustard in the treatment of neo-plastic disease. Ann NY Acad Sci 1958; 68: 899–914.
3. Rhoads CP. Nitrogen mustards in the treatment of neoplastic disease. J Am Med Assoc 1946; 131: 656–658.
4. Goodman LS, Wintrobe MM, Dameshek W, Goodman MJ, Gilman A, McLennan MT. Nitrogen mustard therapy; use of methyl-bis(beta-chloroethyl)amine hydrochloride and tris (betachloroethyl) amine hydrochloride for Hodgkin’s disease, lymphosarcoma, leukemia and certain allied and miscellaneous disorders. J Am Med Assoc 1946; 132: 126–132.
5. Goodman LS, Wintrobe MM, McLennan MR, Dameshek W, Goodman MJ, Gilman A. The use of methyl-bis(beta-chloroethyl)amine hydrochloride and tris(betachloroethyl)amine hydrochloride (“nitrogen-mustards”) in the therapy of Hodgkin’s disease, lymphosarcoma, leukemia and certain allied and miscellaneous disorders. In: Approaches to Tumor Chemotherapy. Washington, DC. 1947: 338–346.